Drug and Gene Delivery Devices
Global Drug and Gene Delivery Devices Market to Reach $1.2 Trillion by 2030
In the changed post COVID-19 business landscape, the global market for Drug and Gene Delivery Devices estimated at US$635.1 Billion in the year 2022, is projected to reach a revised size of US$1.2 Trillion by 2030, growing at aCAGR of 8.6% over the period 2022-2030. Oral, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$582.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Inhalation segment is readjusted to a revised 8.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $173 Billion, While China is Forecast to Grow at 13.3% CAGR
The Drug and Gene Delivery Devices market in the U.S. is estimated at US$173 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$290 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 7.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.
Select Competitors (Total 36 Featured) -
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook